Marketing & Strategy
PRIME Award winners announced; AstraZeneca tops the list
This year, the 15th annual PRIME Awards captured some of the best and the brightest in the pharmaceutical and media industries come together to celebrate their achievements in healthcare communications.
Diligence, creativity and innovation paid off for a record number of finalists who walked the red carpet on Thursday night at Sydney’s Four Season’s Hotel.
Hosted by multi award winning comedian Urzila Carlson, the evening kicked off with some fun and frivolity before taking a different tack with an opening address by Elizabeth de Somer, CEO of Medicines Australia, on progress in the pharmaceutical industry.
AstraZeneca was the biggest winner on the night, scoring the top spot across three major categories.
A productive partnership with McCann Health resulted in the pharma giant nabbing the Creativity in Communication – Prescription award for Zoladex’s “Great Wall of Undies” campaign from five nominations.
AstraZeneca also took home the award for Best PR Campaign and won the top spot in a new category, Sustained Excellence in Bettering Patient Outcomes which recognised the Lung Foundation’s enduring campaign by LIFE agency.
Hot on AstraZeneca’s heels was Gilead, who in collaboration with Ward6 won two awards including the coveted Marketing Campaign of the Year gong.
Other pharma companies who dominated the proceedings were Mylan who scooped up two major awards, along with Servier, Otsuka, Amgen, Sequirus, Bristol-Myers Squib and Biogen who each won first place in one of the 17 categories.
You may also like Assessing clinician and patient motivation
News & Trends - MedTech & Diagnostics
AI-assisted colonoscopy boosts polyp and adenoma detection
MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]
MoreNews & Trends - Pharmaceuticals
‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO
Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]
MoreNews & Trends - Pharmaceuticals
Government’s silence on Senate report leaves cancer patients in limbo
Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]
More